A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC
Clinical trial NCT04063163 · COMPLETED
Trial details
- NCT number
- NCT04063163
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-12
- Primary completion
- 2024-05-07
- Enrollment
- 585
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.